SBC Medical Q1 revenue falls 9% to $43M; net income drops 47% to $11M

SBC Medical Group Holdings Inc

Revenue $43M, -9% YoY; net income $11M, -47% YoY; diluted EPS $0.11, -48% YoY.
EBITDA $18M, -26% YoY; net income margin 26% (down 19pp); EBITDA margin 43% (down 10pp).
CEO attributes revenue decline to April 2025 franchise fee restructuring; core business fundamentals remain solid.
Franchise locations rose 33 to 284; LTM customers up 10% to 6.76M; repeat rate 72%.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SBC Medical Group Holdings Inc reported the three months ended March 31, 2026 results: revenue $43 million, net income $11 million, EPS $0.11.

Period: the three months ended March 31, 2026
Revenue: $43 million
Net income: $11 million
EPS: $0.11
Result: reported results

Exact text from the filing

across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights • Total revenues were $43 million, representing a 9% year-over-year decrease. • Net income attributable to SBC Medical Group Holdings Incorporated was $11 million, representing a 47% year-over-year decrease. Net

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

SBC Medical Group Holdings Inc filing history →

Source: SEC EDGAR

accession 0001193125-26-222720

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.